Literature DB >> 719613

Prolymphocytic leukemia: clinical, histopathological, and cytochemical observations.

R M Bearman, G A Pangalis, H Rappaport.   

Abstract

The clinical, histopathological, and cytochemical features of eight patients with prolymphocytic leukemia, a rare variant of chronic lymphocytic leukemia, were reviewed. Six of the patients had clinical evidence of "massive" splenomegaly at the time of diagnosis, and in four of these this clinical impression was confirmed by splenic weights in excess of 2000 g. No patient had significant lymph node enlargement. The initial leukocyte count was elevated in seven patients and was greater than 100 X 10(9)/1 in four of them. The absolute prolymphocyte count ranged from 16.3 to 378.1 X 10(9)/1 and was greater than 100 X 10(9)/1 in four patients. Splenectomy in four patients had no lasting effect on the peripheral leukocyte count. In the four patients in whom the disease was shown by surface marker or immunocytochemical studies to be of B-cell origin, the histopathologic features were distinctive and were characterized by a pattern of infiltration which was nodular and diffuse in both the splenic red pulp and the bone marrow, whereas involvement of the lymph nodes was pseudonodular. In one patient in whom the prolymphocytes had cytochemical characteristics suggestive of T-cells, the distribution of the abnormal cellular proliferation in the lymph nodes was paracortical and the infiltrations of the spleen and the bone marrow were diffuse.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 719613     DOI: 10.1002/1097-0142(197811)42:5<2360::aid-cncr2820420537>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  A rare case of B-lymphoproliferative disorder with villous lymphocytes harboring t(8;14)(q24;q32) translocation.

Authors:  Xiaofeng Shi; Rong Ba; Haiyan You; Qian Jiang; Jiansong Huang; Jianhua Mao; Lanxiu Han; Shuo Zhang; Qin Zhuang; Xianqiu Yu; Lixia Wang; Yun Wang; Dongya Li; Wei Zhu; Yong Zhang; Yan Zhu; Xiaodong Xi
Journal:  Front Med       Date:  2017-10-27       Impact factor: 4.592

2.  BCL1, a murine model of prolymphocytic leukemia. II. Morphology and ultrastructure.

Authors:  M J Muirhead; J M Holbert; J W Uhr; E S Vitetta
Journal:  Am J Pathol       Date:  1981-12       Impact factor: 4.307

3.  Some data on the proliferative activity of prolymphocytic leukemia.

Authors:  K Donhuijsen; H J Richter
Journal:  Klin Wochenschr       Date:  1980-03-03

Review 4.  Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.

Authors:  Aude Collignon; Anne Wanquet; Elsa Maitre; Edouard Cornet; Xavier Troussard; Thérèse Aurran-Schleinitz
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

5.  Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse.

Authors:  S H Swerdlow; J A Habeshaw; L J Murray; H S Dhaliwal; T A Lister; A G Stansfeld
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

6.  B-lineage prolymphocytic leukemia as a distinct clinicopathologic entity.

Authors:  I Katayama; M Aiba; L Pechet; J L Sullivan; P Roberts; R E Humphreys
Journal:  Am J Pathol       Date:  1980-05       Impact factor: 4.307

7.  BCL1, a murine model of prolymphocytic leukemia. I. Effect of splenectomy on growth kinetics and organ distribution.

Authors:  M J Muirhead; P C Isakson; K A Krolick; J W Uhr; E S Vitetta
Journal:  Am J Pathol       Date:  1981-12       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.